Cumberland Pharmaceuticals
CPIX • NASDAQ
Cumberland Pharmaceuticals is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO A. J. Kazimi, with a market cap of $45.9M.
CEOA. J. Kazimi
Market Cap$45.9M
Drug Manufacturers - Specialty & Generic
Healthcare
Employees91.0
Websitecumberlandpharma.com
Next Earnings
Upcoming earnings announcement for Cumberland Pharmaceuticals
Date
Tuesday, May 5, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
Earnings History
Past 12 earnings reports for Cumberland Pharmaceuticals
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 3, 2026 | Q4 2025 | -$0.01 | — | $13.7M | — | — |
| Nov 4, 2025 | Q3 2025 | -$0.06 | — | $8.3M | — |  10-Q |
| Aug 5, 2025 | Q2 2025 | $0.02 | — | $10.8M | — | 10-Q |
| May 6, 2025 | Q1 2025 | $0.16 | — | $11.7M | — | 10-Q |
| Mar 4, 2025 | Q4 2024 | -$0.02 | — | $10.4M | — | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.02 | — | $9.1M | — | 10-Q |
| Aug 6, 2024 | Q2 2024 | $0.01 | — | $9.8M | — | 10-Q |
| May 7, 2024 | Q1 2024 | -$0.05 | — | $8.5M | — | 10-Q |
| Mar 5, 2024 | Q4 2023 | -$0.11 | — | $9.4M | — | 10-K |
| Nov 7, 2023 | Q3 2023 | $0.02 | — | $10.1M | — | — |
| Aug 8, 2023 | Q2 2023 | $0.16 | — | $10.9M | — | 10-Q |
| May 9, 2023 | Q1 2023 | $0.11 | — | $9.2M | — | 10-Q |